Ernest Raymond

974 total citations
19 papers, 301 citations indexed

About

Ernest Raymond is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Ernest Raymond has authored 19 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Immunology and 3 papers in Genetics. Recurrent topics in Ernest Raymond's work include interferon and immune responses (2 papers), Dermatology and Skin Diseases (2 papers) and Melanoma and MAPK Pathways (2 papers). Ernest Raymond is often cited by papers focused on interferon and immune responses (2 papers), Dermatology and Skin Diseases (2 papers) and Melanoma and MAPK Pathways (2 papers). Ernest Raymond collaborates with scholars based in United States, Germany and Italy. Ernest Raymond's co-authors include M. Lamine Mbow, Siddhartha Saha, Gary Caviness, Keith A. Canada, Rajkumar Ganesan, Rachel Kroe‐Barrett, Eliud Sepulveda, Jennifer Ahlberg, Sanjaya Singh and Lee Frego and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Ernest Raymond

16 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ernest Raymond United States 10 152 81 77 55 39 19 301
Elizabeth Kieras United States 11 233 1.5× 142 1.8× 53 0.7× 152 2.8× 25 0.6× 13 420
Huayang Tang China 9 120 0.8× 34 0.4× 97 1.3× 24 0.4× 47 1.2× 25 266
Subrata Manna United States 8 78 0.5× 30 0.4× 179 2.3× 124 2.3× 84 2.2× 12 358
M. Angela Brazil 6 143 0.9× 10 0.1× 118 1.5× 75 1.4× 41 1.1× 9 339
Aïda Ghoul France 8 44 0.3× 36 0.4× 254 3.3× 85 1.5× 51 1.3× 10 379
Leslie H. Brail United States 8 43 0.3× 17 0.2× 294 3.8× 85 1.5× 23 0.6× 16 385
Cora Bucana United States 8 90 0.6× 59 0.7× 193 2.5× 92 1.7× 4 0.1× 8 337
Jennifer Kimberly Lue United States 11 94 0.6× 57 0.7× 244 3.2× 146 2.7× 13 0.3× 40 435
Les Brail United States 9 75 0.5× 15 0.2× 323 4.2× 108 2.0× 28 0.7× 18 427
Hester Franks United Kingdom 11 260 1.7× 14 0.2× 84 1.1× 219 4.0× 11 0.3× 19 421

Countries citing papers authored by Ernest Raymond

Since Specialization
Citations

This map shows the geographic impact of Ernest Raymond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernest Raymond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernest Raymond more than expected).

Fields of papers citing papers by Ernest Raymond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernest Raymond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernest Raymond. The network helps show where Ernest Raymond may publish in the future.

Co-authorship network of co-authors of Ernest Raymond

This figure shows the co-authorship network connecting the top 25 collaborators of Ernest Raymond. A scholar is included among the top collaborators of Ernest Raymond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernest Raymond. Ernest Raymond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tivey, Trevor, Ernest Raymond, Clinton A. Oakley, et al.. (2025). Stability of the cnidarian–dinoflagellate symbiosis is primarily determined by symbiont cell-cycle arrest. Proceedings of the National Academy of Sciences. 122(14). e2412396122–e2412396122.
2.
3.
Bonfiglio, Rita, Filippo Galli, Michela Varani, et al.. (2021). Extensive Histopathological Characterization of Inflamed Bowel in the Dextran Sulfate Sodium Mouse Model with Emphasis on Clinically Relevant Biomarkers and Targets for Drug Development. International Journal of Molecular Sciences. 22(4). 2028–2028. 12 indexed citations
4.
Saha, Siddhartha, Gary Caviness, Guang‐Hui Yi, et al.. (2017). E3 Ubiquitin Ligase RNF125 Activates Interleukin-36 Receptor Signaling and Contributes to Its Turnover. Journal of Innate Immunity. 10(1). 56–69. 7 indexed citations
5.
Yi, Guanghui, Joel A. Ybe, Siddhartha Saha, et al.. (2016). Structural and Functional Attributes of the Interleukin-36 Receptor. Journal of Biological Chemistry. 291(32). 16597–16609. 39 indexed citations
6.
Bianchi, Andrea, Tanja Schönberger, Ernest Raymond, et al.. (2016). Noninvasive Longitudinal Study of a Magnetic Resonance Imaging Biomarker for the Quantification of Colon Inflammation in a Mouse Model of Colitis. Inflammatory Bowel Diseases. 22(6). 1286–1295. 8 indexed citations
7.
Saha, Siddhartha, Divyendu Singh, Ernest Raymond, et al.. (2015). Signal Transduction and Intracellular Trafficking by the Interleukin 36 Receptor. Journal of Biological Chemistry. 290(39). 23997–24006. 24 indexed citations
8.
Singh, Sanjaya, Rachel Kroe‐Barrett, Keith A. Canada, et al.. (2015). Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody. mAbs. 7(4). 778–791. 94 indexed citations
9.
Neuzillet, Cindy, Lucile Astorgues‐Xerri, Armand de Gramont, et al.. (2012). 398 Benchmarking the Allosteric MEK Inhibitors UO126, AZD6244, AS703026, and GSK1120212 Shows Differences in Potency to Inhibit ERK Phosphorylation, Proliferation, and Invasion in Pancreatic Cancer Models. European Journal of Cancer. 48. 121–121. 1 indexed citations
10.
Delord, Jean‐Pierre, Nadine Houédé, Ahmad Awada, et al.. (2012). 616 Pimasertib (MSC1936369B/AS703026), a Selective Oral MEK1/2 Inhibitor, Shows Clinical Activity in Melanoma. European Journal of Cancer. 48. 190–190. 9 indexed citations
11.
Serova, Maria, Ivan Bièche, Gijsbertus J. Pronk, et al.. (2010). Single agent and combination studies of pralatrexate and molecular correlates of sensitivity. British Journal of Cancer. 104(2). 272–280. 30 indexed citations
12.
13.
Zindell, Renée, Doris Riether, Todd Bosanac, et al.. (2009). Morpholine containing CB2 selective agonists. Bioorganic & Medicinal Chemistry Letters. 19(6). 1604–1609. 16 indexed citations
14.
Winters, Michael P., Steven S. Pullen, Joseph R. Woska, et al.. (2008). 5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk). Bioorganic & Medicinal Chemistry Letters. 18(20). 5541–5544. 18 indexed citations
15.
Boüard, Sophie de, Paulette Herlin, James G. Christensen, et al.. (2006). 58 POSTER Antiangiogenic and anti-invasive activities of the kinase inhibitor sunitinib malate on experimental human gliobalstoma in vitro and in vivo. European Journal of Cancer Supplements. 4(12). 22–22. 1 indexed citations
16.
Cywin, Charles L., Raymond A. Firestone, Daniel W. McNeil, et al.. (2003). The design of potent hydrazones and disulfides as cathepsin S inhibitors. Bioorganic & Medicinal Chemistry. 11(5). 733–740. 25 indexed citations
17.
Carley, Kathleen M., et al.. (2002). Model Comparisons: Docking ORGAHEAD and SimVision. 11 indexed citations
18.
Raymond, Ernest. (1998). [Tumor angiogenesis inhibitors: media and scientific aspects].. PubMed. 27(24). 1221–4. 4 indexed citations
19.
Raymond, Ernest. (1973). We, the Accused. Medical Entomology and Zoology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Kieras Breakdown of academic impact, for papers by Huayang Tang Breakdown of academic impact, for papers by Subrata Manna Breakdown of academic impact, for papers by M. Angela Breakdown of academic impact, for papers by Aïda Ghoul Breakdown of academic impact, for papers by Leslie H. Brail Breakdown of academic impact, for papers by Cora Bucana Breakdown of academic impact, for papers by Jennifer Kimberly Lue Breakdown of academic impact, for papers by Les Brail Breakdown of academic impact, for papers by Hester Franks
Rankless by CCL
2026